Sugarcoating a bitter pill: Identifying how mucinous tumours use glycobiology for chemoresistance

Closing date: 04/04/2025

CRUK Black Leaders in Cancer Non-Clinical PhD Scholarship: Sugarcoating a bitter pill: Identifying how mucinous tumours use glycobiology for chemoresistance

Lead Supervisors: Dr John Knight
Co-Supervisors:
Prof. David Thornton, Dr Paul Sutton

Applications Deadline: Friday 4th April 2025
Interviews: Week commencing 28th April 2025
Non-Clinical Studentship start date: September 2025

Project Keywords: Mucinous tumours; Chemotherapy resistance; Glycobiology
Research Opportunity: Non-Clinical Studentship leading to the award of PhD

Project Outline

Mucinous colorectal cancers are easily identifiable early in a patient’s care due to their extracellular glycan (sugar)-dominated mucus, which accounts for more than 50% of tumour volume. This early identification and the unique changes in the biology that separate mucinous from non-mucinous disease should empower precision medicine. However, no specific treatments exist for mucinous colorectal cancers. Instead, patients follow the same pathway as those with non-mucinous colorectal cancers. Unfortunately, on these parallel care pathways patients with mucinous disease have a significantly worse survival than those with non-mucinous colorectal cancer, in part due to a poorer response to chemotherapy.

Laboratory evidence has shown that cells from mucinous tumours are not innately resistant to chemotherapeutic agents, but rather that the glycan-rich mucus they secrete provides them with a chemoprotective microenvironment. We therefore need to develop specific therapies to target the innate biology of mucinous colorectal cancers to refine or replace the current treatments. To do this we first need to understand the chemoprotective microenvironment generated by mucinous tumours, then find ways to alter this for patient benefit. This project will make this step to improve clinical outcomes. 

The student will join an interdisciplinary team using the unique opportunities available within the Manchester cancer research ecosystem to advance our knowledge of mucinous colorectal cancer. A partnership between academic research labs at The University of Manchester and surgical consultants at The Christie Hospital will isolate mucus from patient tumours and build on our existing living biobank of mucinous colorectal cancer. The student will leverage these resources to catalogue what chemoprotective mucus is made from, how these biomolecules interact with chemotherapy agents and identify targetable pathways required for mucus production. The student will gain extensive skills in molecular and cellular biology and importantly, an understanding of the glycobiology in colorectal cancer. 

Applications for this project are now open. Please complete your application on the Windsor Fellowship website.

About Dr John Knight (project Lead Supervisor)

The Knight lab researches subtypes of colorectal cancer with unmet clinical needs. This includes tumours with specific driver mutations or physical properties. The lab collaborates closely with clinicians from The Christie Hospital to analyse patient tumours using cuttingedge biochemical and molecular methods. The aim of the lab is to develop innovative models and methods to solve specific clinically relevant problems for the benefit of cancer patients. 

Find out more

John Knight headshot

Key information

Before submitting an application, please ensure you have read the information below about the funding arrangements and eligibility for Non-Clinical Studentships.

We also encourage you to get in contact with the lead supervisor to discuss the project and any particulars.

Further information is available on the Non-Clinical PhD Studentships webpage.

Fees and Funding
Eligibility
How to apply
Applications Timelines

Useful Links

Submit your application

Interested in applying for this opportunity? Go to the Windsor Fellowship website to submit your application.

Clinical Research Training Fellowships

Discover our various opportunities for clinicians looking to undertake a period of PhD training in a cancer-relevant field.

Get in Touch

Contact Dr Yasmin Noori Jenaghard, Postgraduate Programme Manager.

Researcher Stories

Read first-hand experiences of from cancer scientists from across Manchester.

Why Manchester?

Find out why postgraduate students choose to study in Manchester.

A Day in the Life of a Clinical PhD Student

Watch our short video to see what it's like to be a Clinical Research Training Fellow in Manchester.